Close association between Fas ligand (FasL: CD95L)-positive tumor-associated macrophages and apoptotic cancer cells along invasive margin of colorectal carcinoma: A proposal on tumor-host interactions

Japanese Journal of Cancer Research

Volumn 93, Issue 3, 2002, Pages 320-328

  Sugita, Junichi ^a   Ohtani, Haruo ^a   Mizoi, Takayuki ^a   Saito, Kazuya ^a   Shiiba, Kenichi ^a   Sasaki, Iwao ^a   Matsuno, Seiki ^a   Yagita, Hideo ^b   Miyazawa, Masaaki ^c   Nagura, Hiroshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti tumor immunity; Colorectal cancer; Fas ligand; Tumor associated macrophages

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INVASION; CELLULAR DISTRIBUTION; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DENDRITIC CELL; EFFECTOR CELL; FEMALE; FROZEN SECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

AGED; ANTIGENS, CD; ANTIGENS, CD95; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS; COLORECTAL NEOPLASMS; FAS LIGAND PROTEIN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 0036233415     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb02175.x     Document Type: Article

References (36)

1. A new prognostic classification of rectal cancer
2. Intercellular adhesion molecule-1 expression by macrophages in human gastrointestinal carcinoma: Possible roles as host immune/inflammatory reaction
3. Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: A possible antitumor immunity?
4. Clinicopathologic significance of urokinase receptor-and MMP-9-positive stromal cells in human colorectal cancer: Functional multiplicity of matrix degradation on hematogenous metastasis
5. + T-cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer
6. Dendritic cells and the control of immunity
7. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
8. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity
9. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes
10. Cytolytic T cell cytotoxicity is mediated through perforin and Fas lytic pathways
11. CD95's deadly mission in the immune system
12. The Fas counterattack: Cancer as a site of immune privilege
13. Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape
14. The tumor counterattack hypothesis revisited: Colon cancer cells do not induce T cell apoptosis via the Fas (CD95m APO-1) pathway
15. Countering the "counterattack" hypothesis
16. Antitumor effect of locally produced CD95 ligand
17. Immune privilege or inflammation? Insight into the Fas ligand enigma
18. Dual overexpression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immunoelectron microscopy
19. Macrophage-derived chemokine (MDC/CCL22) and CCR4 are involved in the formation of T lymphocyte-dendritic cell clusters in human inflamed skin and secondary lymphoid tissue
20. Metalloproteinase-mediated release of human Fas ligand
21. + T-lymphocytes as a prognostic factor in human renal cell carcinoma: Clinicopathologic demonstration of anti-tumor immunity
22. Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer
23. Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis
24. Expression of Fas ligand in liver metastasis of human colonic adenocarcinoma
25. Fas/Fas ligand interaction in human colorectal hepatic metastases: A mechanism of hepatocyte destruction to facilitate local tumor invasion
26. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas
27. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by Fas counterattack in human colorectal carcinoma and its correlation with prognosis
28. Human monocytic cells contain high levels of intracellular Fas ligand: Rapid release following cellular activation
29. The expression of Fas ligand by macrophages and its upregulation by human immunodeficiency virus infection
30. Phagocytosis triggers macrophages release of Fas ligand and induces apoptosis of bystander leukocytes
31. Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elimination of tumor cells
32. Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo
33. The microenvironment of the tumour-host interface
34. Inflammation and cancer: Back to Virchow?
35. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts
36. The intriguing role of polymorphonuclear neutrophils in antitumor reactions